Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes, with focus on wound care and surgical procedures. Products are used by surgeons and medical personnel to help over 65 million patients in over 90 countries world-wide. Mölnlycke’s ambition is to make the lives of patients better.

Mölnlycke, headquartered in Gothenburg, Sweden, is a world-leading specialist provider and innovator of single-use wound care and surgical products. It has a long history of challenging the status quo and, through innovation, create advanced wound care products that reduce the healing time and suffering of patients. This approach has made Mölnlycke the market leader within advanced wound care dressings. In addition, Mölnlycke is a pioneer in the field of dressings and other products for the prevention of wounds, such as pressure ulcers. Mölnlycke also makes the operating room more efficient with innovative and safe surgical solutions. Cutting-edge and cost-efficient products have made Mölnlycke the company it is today.

Over the years the entrepreneurial and innovative spirit that characterizes Mölnlycke has resulted in an R&D-department that is committed to bringing new, innovative products to the market. Also, demographic factors, such as an aging population and an increase in surgical procedures, have created a greater demand for high-quality medical products. This has in turn resulted in growth and improvements further reinforcing our offering to the market. Mölnlycke has grown strongly since it was acquired over the years. Successful acquisitions have also been made to complement the product offering.



Mölnlycke successfully launched a new range of advanced wound care dressings, Mepilex® Border Flex, which has been well received by the market. The dressings offer better conformity and wear time, better absorption and also improved bacteria containment.

In mid-2018 Mölnlycke acquired SastoMed, a German company offering products for acceleration of healing and treatment of chronic wounds. The addition of these products strengthens Mölnlycke’s offering within both active and passive wound healing.

In the beginning of 2019 Mölnlycke acquired M&J Airlaid, a manufacturer of a key component in Mölnlycke’s best-selling wound care dressings. The acquisition supports Mölnlycke’s growth ambitions and adds critical R&D capabilities.


Click here for Mölnlycke's website

Mölnlycke -  Key facts

EUR m.









Number of employees



Patricia Industries ownership (capital/votes): 99/99  |  Initial investment year: 2007 (sole owner 2010)